Cedars-Sinai Medical Center

St. Marianna University School of Medicine

Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval

Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma

Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives!

New Strategies For Cancer Vaccines: Transforming Cancer Cells So They Can Become Cancer-Fighters Is Not Far Away!